Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

 3,200.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 5,060.00
  • 52 Week Low: 3,170.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 2,929
  • Market Cap: £167.03m

Bioventix Overview

Bioventix was founded in 2003 as a biotechnology company specialising in the creation and supply of high-affinity sheep monoclonal antibodies (SMAs) for use in immunodiagnostics. However, the antibody technology laboratory and some of the staff have been based at the same location in Farnham, Surrey, UK since the early 1990s.

1 Day Chart (24-12-2024)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 4.8% 0.0%
Div Cover 1.0 1.1
Op Mrgn 77.8% 79.3%
ROCE 75.6%  
Latest F'cast
P/E 20.6 18.7
PEG n/a 1.8
Pr/Revenue 12.3 11.5
Pr/Book 13.9  
Latest F'cast
Revenue 6.2% 6.6%
PBT 4.6% 8.5%
EPS -3.4% 10.2%
DPS 2.0% 3.2%

Bioventix Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-20 10.31 8.23 139.41p 29.8 1.4 +22% 88.00p 2.1%
30-Jun-21 10.93 8.12 129.22p 30.7 n/a -7% 105.00p 2.6%
30-Jun-22 11.72 9.28 147.32p 23.4 1.7 +14% 126.00p 3.7%
30-Jun-23 12.82 10.13 160.63p 24.0 2.7 +9% 152.00p 3.9%
30-Jun-24 13.61 10.60 155.12p 28.4 n/a -3% 155.00p 3.5%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Bioventix Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-25 14.50 11.50 171.00p 18.7 1.8 +10% 160.00p 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Bioventix Company Announcements

Director Dealing 24-Dec-2024 09:14 RNS
Result of AGM 06-Dec-2024 07:00 RNS
Holding(s) in Company 04-Dec-2024 15:34 RNS

Latest Bioventix Director Deals

Traded Action Notifier PriceAmountValue
23-Dec-24 Buy Bruce Hiscock 273.00p 61 £166.53
22-Nov-24 Buy Bruce Hiscock 3,822.00p 24 £917.28
30-Oct-24 Buy Bruce Hiscock 3,330.00p 300 £9,990.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Bioventix Market Data

Currency UK Pounds
Share Price 3,200.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 5,060.00
52 Week Low 3,170.00
Volume 2,929
Shares Issued 5.22m
Market Cap £167.03m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
44.99% below the market average44.99% below the market average44.99% below the market average44.99% below the market average44.99% below the market average
96.00% above the sector average96.00% above the sector average96.00% above the sector average96.00% above the sector average96.00% above the sector average
Price Trend
52.86% below the market average52.86% below the market average52.86% below the market average52.86% below the market average52.86% below the market average
10.2% below the sector average10.2% below the sector average10.2% below the sector average10.2% below the sector average10.2% below the sector average
Income
21.95% above the market average21.95% above the market average21.95% above the market average21.95% above the market average21.95% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
40.33% below the market average40.33% below the market average40.33% below the market average40.33% below the market average40.33% below the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average

Bioventix Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 07-Nov-24 11-Apr-24
Paid 21-Nov-24 26-Apr-24
Amount 87.00p 68.00p

Trades for 24-Dec-2024

Time Volume / Share Price
12:06 550 @ 3,174.76p
12:05 380 @ 3,210.00p
12:05 380 @ 3,200.00p
12:04 305 @ 3,275.00p
11:08 60 @ 3,275.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page